In the trial backed by Johnson & Johnson and GlaxoSmithKline, people living with the virus were given a shot containing two drugs every four or eight weeks. At both intervals, the shot worked just as well as people who were taking three pills per day to suppress their virus, Reuters reports.
Having an alternative method of helping people stay HIV-undetectable is important for public health and for the personal health of those living with the virus. Currently, only 30% of the 1.2 million people living with HIV in the U.S. are undetectable.
Great job, Johnson & Johnson!